The purpose of the POI Industry Advisory Board (IAB) is to advise and support POI in relation to industry partner objectives, direction and overall programme strategies. The IAB promotes POI as an innovative research programme for Ireland.
We are proud to have the following representation on our IAB;
Mr. Tommy Bracken (Hexagon Consulting, CRC-UCD and Chairperson, POI IAB)
Dr. Claus Bendtsen (AstraZeneca)
Dr. Steven Griffin (Cell Stress Discoveries)
Dr. David Kavanagh (Genuity Science)
Dr. Remco Loos (Celgene)
Dr. Helen McCarty (Phion Therapeutics)
Mr. Des O’Leary (OncoMark)
Mr. Padraig Somers (Helsinn)